Amit Etkin's guest appearances

Amit Etkin

Empowered Patient Podcast

Podcasts360

Stigma Podcast - Mental Health

Emily O'Brien

Chris Palmer

Travis Mickle

Justin Miller

Mark Pimentel

Sean Tucker

Matt Wilson

Chris Young

Thomas Keller

Nick Allen

Jim Martin

Clay Cockrell

Robin Zander

Andrew Newberg

Mike Rea

OwlTail

Dr. Amit Etkin is pioneering a revolution in the way mental health medications are designed, developed, prescribed, and brought to market.  Precision psychiatry is the future of mental health treatment and Dr. Etkin is leading the way with his drug development platform, Alto Neuroscience.  In this episode, Dr. Etkin explains why psychiatric drugs have failed, what he is doing about it and why it will work.  Prior to Alto Neuroscience, Dr. Etkin was a tenured professor in the Department of Psychiatry and Behavioral Sciences at Stanford University and a member of the Wu Tsai Neurosciences Institute. Dr. Etkin has received multiple awards, most notably the NIH Director’s Pioneer Award in 2017. He is trained as both a psychiatrist and neuroscientist. The overarching aim of his work in this field for the last 10 years is to understand the neural basis of emotional disorders and their treatment, and to leverage this knowledge to better understand how the brain works and to develop novel treatment interventions. In support of this goal, Dr. Etkin also collaborates with neuroscientists, engineers, psychologists, physicians, and others to establish a new intellectual, scientific, and clinical paradigm for understanding and manipulating human brain circuits in healthy individuals and for treating psychiatric disease. You can connect with Amit here:  LinkedIn Alto Neuroscience Website: https://www.altoneuroscience.com/ What If Fellowship: https://whatif.vc/fellowship   HERE ARE SOME OF THE THINGS WE TALKED ABOUT:  Etkin shares his background, why he got into the field of neuroscience, and why he is building Alto Neuroscience.   We discuss the biggest needs in the clinical psychology world is and how Alto Neuroscience will solve some of the greatest needs in the mental health space.   We talk about measurement &amp; testing, as well as biomarkers in the mental health space at large and why we are so far behind other healthcare verticals when it comes to measurement and testing in the mental health space.   Etkin explains that one of the primary reasons bio-pharma companies haven’t focused as much as they should on Central Nervous System (CNS) drug development in the last couple of decades is because we can’t effectively measure how the drugs are working. All of that has changed now with the creation of Alto Neuroscience.    Amit talks about the concept of “precision psychiatry”, how precision is utilized in other fields of medicine, and the importance of using it in the mental health space to improve treatment options.   We discuss how the combination of measurement and precision psychiatry can change psychiatry, drug development, and treatment of mental health disorders both broadly on a macro level and specifically with respect to his work at Alto Neuroscience.   Amit shares about what Alto Neuroscience is currently working on, the drugs they currently developing, and their vision for the future of psychiatric medication.    Connect with the Stigma Podcast in the following ways: Website, Twitter, Facebook, LinkedIn, Email  Connect with host Stephen Hays here: Stephen Hays Personal Website, Twitter, LinkedIn, What If Ventures (Mental Health Venture Fund)

Dr. Amit Etkin is pioneering a revolution in the way mental health medications are designed, developed, prescribed, and brought to market.  Precision psychiatry is the future of mental health treatment and Dr. Etkin is leading the way with his drug development platform, Alto Neuroscience.  In this episode, Dr. Etkin explains why psychiatric drugs have failed, what he is doing about it and why it will work.  Prior to Alto Neuroscience, Dr. Etkin was a tenured professor in the Department of Psychiatry and Behavioral Sciences at Stanford University and a member of the Wu Tsai Neurosciences Institute. Dr. Etkin has received multiple awards, most notably the NIH Director’s Pioneer Award in 2017. He is trained as both a psychiatrist and neuroscientist. The overarching aim of his work in this field for the last 10 years is to understand the neural basis of emotional disorders and their treatment, and to leverage this knowledge to better understand how the brain works and to develop novel treatment interventions. In support of this goal, Dr. Etkin also collaborates with neuroscientists, engineers, psychologists, physicians, and others to establish a new intellectual, scientific, and clinical paradigm for understanding and manipulating human brain circuits in healthy individuals and for treating psychiatric disease. You can connect with Amit here:  <a href="https://www.linkedin.com/in/amit-etkin-783a04158/" rel="nofollow" target="_blank">LinkedIn</a> Alto Neuroscience Website: <a href="https://www.altoneuroscience.com/" rel="nofollow" target="_blank">https://www.altoneuroscience.com/</a> What If Fellowship: <a href="https://whatif.vc/fellowship" rel="nofollow" target="_blank">https://whatif.vc/fellowship</a> HERE ARE SOME OF THE THINGS WE TALKED ABOUT: <ol> <li>Etkin shares his background, why he got into the field of neuroscience, and why he is building Alto Neuroscience. </li> <li>We discuss the biggest needs in the clinical psychology world is and how Alto Neuroscience will solve some of the greatest needs in the mental health space. </li> <li>We talk about measurement &amp; testing, as well as biomarkers in the mental health space at large and why we are so far behind other healthcare verticals when it comes to measurement and testing in the mental health space. </li> <li>Etkin explains that one of the primary reasons bio-pharma companies haven’t focused as much as they should on Central Nervous System (CNS) drug development in the last couple of decades is because we can’t effectively measure how the drugs are working. All of that has changed now with the creation of Alto Neuroscience.  </li> <li>Amit talks about the concept of “precision psychiatry”, how precision is utilized in other fields of medicine, and the importance of using it in the mental health space to improve treatment options. </li> <li>We discuss how the combination of measurement and precision psychiatry can change psychiatry, drug development, and treatment of mental health disorders both broadly on a macro level and specifically with respect to his work at Alto Neuroscience. </li> <li>Amit shares about what Alto Neuroscience is currently working on, the drugs they currently developing, and their vision for the future of psychiatric medication.</li> </ol> Connect with the Stigma Podcast in the following ways: <a href="https://stigmapodcast.com/" rel="nofollow" target="_blank">Website</a>, <a href="https://twitter.com/StigmaCast" rel="nofollow" target="_blank">Twitter</a>, <a href="https://www.facebook.com/Stigma-Podcast-105616270782583/" rel="nofollow" target="_blank">Facebook</a>, <a href="https://www.linkedin.com/company/stigma-podcast/" rel="nofollow" target="_blank">LinkedIn</a>, <a href="mailto:info@stigmapodcast.com">Email</a> Connect with host Stephen Hays here: <a href="https://stephenrhays.com/" rel="nofollow" target="_blank">Stephen Hays Personal Website</a>, <a href="https://twitter.com/hazesyah" rel="nofollow" target="_blank">Twitter</a>, <a href="https://www.linkedin.com/in/stephen-hays-71b571101/" rel="nofollow" target="_blank">LinkedIn</a>, <a href="https://whatif.vc/" rel="nofollow" target="_blank">What If Ventures (Mental Health Venture Fund)</a>

#89 - The Future of Precision Psychiatry with Dr. Amit Etkin of Alto Neuroscience

Amit Etkin, MD, PhD, of Stanford University and Alto Neuroscience, discusses a recent study examining the use of EEG as a tool in depression treatment. More at: bit.ly/DepressionCare360.

Amit Etkin, MD, PhD, of Stanford University and Alto Neuroscience, discusses a recent study examining the use of EEG as a tool in depression treatment. More at: <a href="http://bit.ly/DepressionCare360" rel="nofollow" target="_blank">bit.ly/DepressionCare360</a>.

Amit Etkin on EEG as a Tool in Depression Treatment

Amit Etkin MD PhD is a professor of psychiatry and behavioral sciences at the Stanford School of Medicine and expert in the neural basis of emotional disorders.  He talks about a recent study published in Science Translational Medicine, of which he was the lead author physician, on his research that lead to the discovery of the first imaging biomaker for PTSD.  Using fMRI and TMS with EEG, Amit was able to identify which patients were most likely to be helped by different treatment plans for post-traumatic stress disorder.  This research was funded in part by Cohen Veterans Bioscience, a translational research organization dedicated to fast-tracking personalized diagnostics and therapeutics for brain health. Cohen Veterans Bioscience

Amit Etkin MD PhD is a professor of psychiatry and behavioral sciences at the Stanford School of Medicine and expert in the neural basis of emotional disorders.  He talks about a recent study published in Science Translational Medicine, of which he was the lead author physician, on his research that lead to the discovery of the first imaging biomaker for PTSD.  Using fMRI and TMS with EEG, Amit was able to identify which patients were most likely to be helped by different treatment plans for post-traumatic stress disorder.  This research was funded in part by Cohen Veterans Bioscience, a translational research organization dedicated to fast-tracking personalized diagnostics and therapeutics for brain health. <a href="http://cohenveteransbioscience.com" rel="noopener nofollow" target="_blank">Cohen Veterans Bioscience</a>

Implications of First Imaging Biomarker for PTSD with Dr. Amit Etkin Stanford School of Medicine